John Taylor, MD, MS

Co-leader, Experimental Therapeutics

John Taylor

Dr. John A Taylor, III is Professor, Director of Basic Urologic Research and the Co-Leader of the Experimental Therapeutics Program at the University of Kansas Medical Center. A native of New York, he completed his Medical Degree at Columbia University’s College of Physicians & Surgeons in New York City, where he stayed to complete his internship and residency in general surgery and urology. He subsequently served for three years on active duty at Walter Reed Army Medical Center, where he was Director of Medical Education for Urology and Assistant Professor at USUHS. After completing his military obligation, he took a faculty position at the University of Connecticut Health Center during which time he completed a Master’s Degree in Clinical and Translation Science, and was promoted to Professor. 

Dr. Taylor is an avid translational researcher with an active lab which pursues novel drug discovery/therapeutics for bladder cancer. He has enjoyed continued extramural funding inclusive of grants and philanthropic donations since 2005, which has included a Jahnigen Scholars Award from the American Geriatrics Society, an American Geriatrics Society/John A. Hartford Foundation Geriatrics Education for Specialty Residents educational grant, an American Cancer Society Mentored Research Scholar Award and a National Institutes of Health R01 as a co-investigator. Most recently, his lab and research have been supported by continual philanthropic donation from the Albert Charitable Trust. His work has been recognized by multiple peer-reviewed publications and several US provisional/full patents. In addition, he is engaged in clinical trials exploring new therapeutics for treatment of bladder cancer. 

Dr. Taylor has served on numerous regional and national committees. While at UConn, he was on the IRB and Chair of the Cancer Committee. He was on the New England Section of the AUA’s Scientific Review Committee, Judicial and Ethics Committee, with appointment as Chair with representation to the AUA, and the Board of Directors for 5 years. He was selected for and graduated from the AUAs leadership class, served on the AUA Young Urologist Committee and is on the AUA Research Council with most recent appointment to the Research Grants and Investigator Support Workgroup. He was invited to partake in the 35th Anniversary Steering Committee of the AUA Foundation, the National Urological Research Agenda Planning Group and the National Institutes of Health/NIDDK, Urology 2.0 Working Group. In addition, he was a participant in the National Cancer Institute’s Bladder Cancer Task Force for Clinical Trial Development and the Society for Immunotherapy of Cancer, Cancer Immunotherapy Guidelines-Genitourinary-Bladder Task Force. He was appointed to the Editorial Board of the Journal of Urology, and is a member of the Bladder Cancer Research Network Management Committee, which oversees the research and development arm of the Bladder Cancer Advocacy Network. He also acts as an external reviewer for the FDA committee on novel treatment of bladder cancer. Most recently he founded the Leo & Anne Albert Institute for Bladder Cancer Care and Research where he is President & Director. 

Dr. Taylor’s practice focuses on caring for and treating patients with bladder cancer.

Clinical Trials

Medical research finds ways to help people live longer, improve their quality of life and manage or cure disease. This is possible because of the people who volunteer to participate in clinical trials.

Learn more about clinical trials »
View clinical trials »